Bioprospecting, Pathogens and Genetic Models
EMU Biological Collections Infrastructure: Acquisition of a Multi-User Platform for Microbiological Collections aimed at Bioprospecting, Pathogens and Genetic Models (BIPAGEN) is a project that proposes the creation of a multi-user platform for the storage, characterization, exchange, and safe use of microbiological collections encompassing microorganisms of interest in bioprospecting, clinical and veterinary pathogens, and genetic models for basic research.
The platform integrates high-standard physical infrastructure for microbial preservation, digital collection management systems, and biosafety protocols, serving as a national hub for academic collaboration and technology transfer. Brazil holds one of the largest microbial biodiversities on the planet, still under-explored. Many strains with potential for antibiotics, enzymes, biopolymers, or pharmaceutical and agricultural compounds remain restricted to isolated labs without unified management or structured sharing.
Dr. Gustavo H. Goldman, PhD
FCFRP-USP
The BIPAGEN collection offers strains in four categories. Prices are per strain and include a basic technical datasheet.
| Category | Description | Examples | Public Universities | Private Sector |
|---|---|---|---|---|
| 1 — Basic Strains | Common, non-pathogenic, easy to cultivate. | E. coli K-12, Bacillus subtilis 168, wild-type Saccharomyces cerevisiae. | R$ 200,00 | R$ 400,00 |
| 2 — Standard Strains | Non-pathogenic bacteria, yeasts, and filamentous fungi with specific characteristics. | Pseudomonas putida, Lactobacillus spp., Aspergillus niger (non-toxigenic). | R$ 300,00 | R$ 600,00 |
| 3 — Specialized Strains | Biosafety Level 2 (BSL-2) pathogens, fastidious microorganisms, or strains with common vectors/plasmids. | Staphylococcus aureus (ATCC 25923), Salmonella enterica, E. coli BL21(DE3) + pET plasmid. | R$ 500,00 | R$ 1.000,00 |
| 4 — Premium Strains | Patented strains, high commercial value, complex genetic constructs, or BSL-3 pathogens (with specific legal restrictions). | Patented enzyme/antibody-producing strains, Mycobacterium tuberculosis (BSL-3), specific knockout strains. | R$ 600,00 – R$ 1.500,00 | R$ 1.200,00 – R$ 3.000,00 |
Our collection is registered at: SiBBr and SpeciesLink (CRIA).
Technical Team: Dra. Marcela Savoldi (PhD in Genetics, FMRP-USP) and Livia Alfaya (MSc, FMRP-USP).